Small, high-quality, European studies using the CamAPS HX algorithm with a tubed insulin pump in the hospital have shown consistent improvements in time-in-range (TIR) compared with standard-of-care MDI insulin regimens.17–19 These data suggest that using AID can improve glycemic control and avoid iatrogenic hypoglycemia in noncritically ill hospitalized patients. This evidence concerns the gene INS and Hypoglycemia.